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ABSTRACT
A degenerative disease-like phenotype, specifically reduction in synaptic protein levels
in adult worms, is correlated with loss-of-function of the only RFX transcription factor gene,
daf-19, in C. elegans. This gene encodes four known transcription factor isoforms, two of which
are correlated with particular functions. The DAF-19C isoform activates genes responsible for
cilia development, while DAF-19M is needed for cilia specification in males. A comparison of the
transcriptome of daf-19 null and isogenic wild type adult worms suggests both positive and
negative regulation of gene expression is correlated with the presence of DAF-19 proteins. We
have assessed DAF-19 regulation of gene expression using transcriptional fusion constructs of
putative target genes in daf-19 wild type and mutant worms. We have found that at least three
genes are repressed by the DAF-19 transcription factor in particular nerve cells. In one case,
differential gene expression is seen in sensory neurons while differential expression of two
other genes is limited to interneurons. Interestingly, none of these genes have been shown to
contain an X-box, the cis-acting sequence used to activate genes involved in cilia formation.
These data suggest that DAF-19 has an additional role beyond that of sensory neuron
development and specification. Because the daf-19 gene produces at least four related
proteins, further experimentation is required to determine which DAF-19 isoform(s) are
responsible for repression of gene expression. We are currently using new alleles of daf-19 to
determine whether the largest DAF-19 proteins, DAF-19A/B have a role in repressing target
gene expression.
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INTRODUCTION:
The development of the nervous system depends on setting aside cells to eventually
become the nervous system. Presumptive nerve cells must then migrate to adult positions,
differentiate, grow axons and dendrites, form functional synapses, and survive (Hobert, 2005;
Schmitz, 2007; Middlelkoop, 2014). All cells, including neurons, have the same genetic
information in their nucleus in the form of tightly wound DNA. However, not all cells express
the same genes. It is the unique expression of different gene combinations that distinguishes a
neuronal cell from other cell types. For example, nerve cells contain the same 19,735 genes
that are found in all C. elegans cells but typically only express a subset of those genes at any
given time (Hillier et al., 2005). Both expression and repression of genes are responsible for
establishing a wide array of cell types with varying shapes, functions, and locations. Some
neurons express greater or fewer genes than other neurons, depending on whether the neuron
is specialized for sensation, movement, or it becomes an interneuron connecting sensory and
motor neurons to one another.
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The Nervous System of C elegans

Figure 1. A partial depiction of the C. elegans neuronal network. Long tracts
represent axons and dendrites. Spheres represent neuronal cell bodies. Anterior of
the worm is facing the left while the posterior of the worm faces the right. Credit:
The OpenWorm Project, image generated by neuroConstruct

In C. elegans, the cells of the nervous system are organized into clusters called ganglia.
The majority of these clusters can be found in the heads and tails of worms. The majority of C.
elegans neurons are located in the head around the pharynx. In addition, there are two small
posterior lateral ganglia on the sides, as well as some scattered neurons along the lateral body.
The processes from most neurons travel in either the ventral or dorsal nerve cord and project
to the nerve ring (NR) in the head. The nerve ring constitutes the major neuropil in animals.
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C. elegans is a powerful model organism that can be used as a developmental and
genetic tool for neuronal studies. The transparency of this worm allows scientists to visualize its
cells in vivo throughout its entire lifespan. Consequently, this worm is the only organism for
which the entire cell lineage is known (Ward et al., 1975; Sulston, 1983). That is, every cell in its
body can be traced to the beginning of the worm’s development and its path of differentiation
is known (Huang & Sternberg, 2005). Similarly, it is the only animal for which each cell has been
fully mapped, such that the developmental birth and death of every single cell, including
neurons, is known (see Figure 1; Varshney, 2011). What is even more fascinating is that these
pioneering studies also revealed how all of these neurons are connected to one another—the
so-called connectome—which is allowing researchers to better link the particular function of
single neurons to the entire neural circuit (Chalfie et al., 1985; Hart, 2006).
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Neurons have two functional ends (Figure 2). This basic functional morphology of
neurons in C. elegans parallels the functional organization of neurons in the human nervous
system. This basic functional feature involves a simple “input-output” mechanism. In the input
portion of this mechanism, sensory projections (dendrites) at one end of the neuronal cell body
receive information from other neurons or directly from the environment via antennae-like
devices named “cilia” that sense their chemical and physical environments. Information is then
transmitted to the cell body. After being processed in the cell body, an outgoing neural signal
will be sent to the other end of the cell—through the neuron’s axon, the outgoing projection of
a neuron.

Axonal Signal Output

Dendritic Sensory Input

Figure 2. The overall structure of a neuron. Neural signals initiate at the
dendrites or soma, then travel through the axon to the terminal buttons, and
synapse onto other neurons, tissues, or glands. Image taken from:
http://neuropsychologysket-ches.com/Neurons.html
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There are four main types of neuronal cell identities in C. elegans that share the
aforementioned “input-output” mechanism: ciliated sensory neurons, non-ciliated sensory
neurons, interneurons (or polymodal neurons) and motor neurons (Hobert, 2005; Varshney,
2011). Interneurons connect ciliated and non-ciliated neurons in different combinations, while
motor neurons connect the nervous system to muscle cells (Varshney, 2011). Cilia are
antennae-like sensory receptors that project from particular neuronal cells inside C. elegans to
either the internal body of the worm or the outside environment, see Figure 4 (Ward, 1975;
Blacque et al., 2005; Inglis et al., 2008). Cilia have different structures, and thus different
functions (Figure 4). This allows ciliated neurons to directly collect and transmit a wide range of
internal and environmental signals to other cells within the worm, including neurons and
muscles. Non-ciliated sensory neurons, interneurons, and motor neurons play a large role in the
conduction and coordination of internal and environmental signals to produce a variety of net
behavioral outputs.
Both ciliated and non-ciliated neurons release neurotransmitters to communicate with
one another. Therefore, it is important to understand the mechanisms that regulate the
specification of neuronal cells into both ciliated and non-ciliated neurons. This developmental
mechanism is especially important to understand, because neurodegenerative disease like
Alzheimer’s, Huntington’s, and Parkinson’s are associated with the loss of synaptic proteins in
neuronal cells (Arnaud et al., 2006).

Ek-Vazquez, 5

A

B

C

Figure 3. Neurons in C. elegans have two functional ends: the sensory input, or dendritic
end, and the signal output, or axonal projection. In a C. elegans, a neuron’s cell body can
have two projections if it is a bipolar neuron (A), or one projection if it is a monopolar neuron
(B). Any other branching (C & D) just extends from these two primary cell projections. Taken
from WormAtlas.
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Figure 4. Different C. elegans ciliary structures with descriptions of their functions. These dendrite-ends absorb DiI. Taken from
WormAtlas.

Regulation of Genes in the C. elegans Nervous System
Gene expression is activated by proteins called transcription factors, which physically
bind to DNA and initiate the transcription of nearby genes into mRNA. Following translation of
mRNAs, the resulting proteins can function as enzymes, ion channels, receptors, structures, or
other transcription factors. Gene expression also can be repressed by proteins whose
expression is activated by transcription factors. In other words, the activation of one or multiple
genes by a transcription factor may lead to the repression of other genes. Therefore,
transcription factors can be indirectly involved in the repression of genes. The observation of
both repression and activation of genetic expression is called differential gene expression.
Differential gene expression is driven in some cells of the C. elegans nervous system by
the daf-19 transcription factor gene, which encodes the RFX transcription factor protein, DAF19. RFX transcription factor genes, like the daf-19 gene, are important to study because they
control the expression of genes involved in the maintenance and survival of a healthy nervous
system (Bonnafe, 2004; Senti & Swoboda, 2008; El Zein et al., 2009; Segun-Estevez et al., 2009;
Piasceki et al., 2010). A full deletion of the daf-19 gene impedes the expression of genes that
are dependent on DAF-19 for transcription. A complete deletion of the daf-19 gene correlates
with a reduction in synaptic protein levels in adult worms and neurodegenerative-disease-like
symptoms as well as the abolition of all ciliary structures on sensory neurons (Swoboda, 2000;
Chen et al., 2006; Inglis et al., 2008; Senti & Swoboda, 2008). Consequently, the absence of the
daf-19 gene can lead to diseases of the nervous system, like Alzheimer’s, Huntington’s, and
Parkinson’s disease. This neurodegenerative mechanism is important to understand because
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orthologs of the daf-19 transcription factor gene exist in the human genome (Aftab et al.,
2008). Versions of the daf-19 gene, called RFX transcription factor genes, have also been found
in Drosophila, Saccharomyces cerevisiae, Schizosaccharomyces pombe, and mouse (Emery et
al., 1996; Vandaele et al., 2001; Dubruille et al., 2002). Therefore, RFX transcription factors
orthologous to DAF-19, are thought to be conserved across the entire eukaryotic kingdom
(Emery et al., 1996). This makes C. elegans a powerful model organism to understand the role
of RFX transcription factors in neurodegeneration (Driscoll et al., 2003; Link, 2005; Murakami,
2007).
DAF-19 proteins (green ribbons in Figure 5) bind to DNA and control the expression of
other genes. More specifically, once bound to a specific DNA sequence, a DAF-19 protein will
recruit or activate the assembly of transcription machinery at nearby transcription start sites.
The daf-19 gene encodes four different versions, or
isoforms, of related DAF-19 transcription factor
proteins. The availability of different versions of the
DAF-19 protein allows for differential gene
regulation by different isoforms of the same gene.
These daf-19 isoforms differentially regulate genes
found in the nervous system. When the daf-19
Figure 5. DAF-19 RFX transcription
factor (green) binding to DNA. Taken
from RFX1 image on Wikipedia.

gene is expressed, exon splicing sometimes creates
longer or shorter versions of the DAF-19
transcription factor protein. The short versions of
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DAF-19 (DAF-19C and DAF-19M) have been found to bind to specific, evolutionarily conserved
DNA sequences called x-boxes in the promoter regions of target genes (Zhang et al., 1993;
Efimenko, 2005). Not only do the short versions of DAF-19 activate genes differentially
themselves, they also work in conjunction with different x-boxes to regulate the location and
intensity of gene expression (Chu et al., 2012; Henriksson et al., 2013). Therefore, the
combination of both different DAF-19 transcription factor proteins and different DAF-19 DNA
target sequences (x-boxes) contribute to the differential regulation of gene expression.
Only two of the DAF-19 protein isoforms have identified functions (Senti and Swoboda,
2008; Wang et al., 2010). The functions of the smaller proteins, DAF-19C and DAF-19M, are well
known. The DAF-19C isoform is expressed exclusively in ciliated sensory neurons, where it
activates genes responsible for cilia development (Swoboda, 2000; Dubruille et al., 2002; Chen
et al., 2006; Senti & Swoboda, 2008). This process, called ciliogenesis, is responsible for the
generation of cilia, which are antennae-like protrusions from the dendrite that permit neuronal
cells to sense particular chemicals, for example, in their environment. The DAF-19M isoforms
control neuronal gene expression in particular ciliated neurons in the male tail and can be said
to specify the function of these neurons (Wang et al., 2010). Thus, DAF-19C specifies a neuron
as a ciliated sensory neuron while DAF-19M specifies the identity of particular ciliated sensory
neurons in males only.
The daf-19 gene produces two closely related longer proteins called DAF-19A/B whose
functions are unknown (Swoboda, 2000; Senti & Swoboda, 2008). In collaboration with
researchers at the Karolinska institute, we hypothesize that the DAF-19A/B protein isoforms are

Ek-Vazquez, 10

responsible for controlling neuronal gene expression in non-ciliated neurons. Further, Senti &
Swoboda (2008) showed that worms lacking all DAF-19 proteins showed marked reductions in
synaptic proteins as adults (but corresponding RNA levels were normal) whereas daf-19 null
worms expressing DAF-19A protein from an added cDNA clone had normal synaptic protein
levels at the same ages. Thus, DAF-19A is said to rescue this synaptic phenotype. We therefore
further hypothesize that DAF-19A is responsible for controlling the expression of genes that
maintain synaptic protein levels, either directly or indirectly.

The DAF-19 Project

Of6-53bp

Figure 6. daf-19 isoforms. daf-19 encodes four different proteins. DAF-19C
directs cilia formation. DAF-19M confers some cilia identity in males. DAF-19A/B
have unknown functions. Adapted from Wang et al. (2010).
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Lab

Strain

Genotype

Description

LU

628

daf-19(tm5562) six times backcrossed

865 bp deletion as follows: 583 bp from
intron 1 + 189 bp exon 2 (entire exon) +
93 bases of intron 2. Only exon 2 in
both DAF-19A and B is deleted.

LU

3063

daf-19(m86)II

Changes an arginine codon to a UGA
stop codon (called an opal mutation) in
exon 7. Lacks all DAF-19 proteins.

LU

3738

daf-19(WT); daf-12(sa204)X; him- Contains all DAF-19 proteins
5(e1490)V

LU

652

daf-19(of6); him-5(e1490)
sEX:pC52D10.6

53 bp deletion of the 3' end of exon 4,
including the splice site at the 3' end.
Mutation affects only DAF-19B isoform

OF

5

daf-19(of5)II

A net deletion of 12 bases (16 bp
deletion and a 4 bp insertion that
includes an ATG in the +1 reading
frame).

LU

664

daf-19(m86); daf-12(sa204); him5 + daf-19C from pGG14 + elt2::gfp

The daf-19(m86) allele was
supplemented with a transgene
containing a cDNA copy expressing
DAF-19C.

LU

668

daf-19(m86); daf-12(sa204);him5 + daf-19A unc-122::gfp and
F57B10.9::gfp

The daf-19(m86) allele was
supplemented with a transgene
containing a cDNA copy expressing
DAF-19A.

The long isoforms of daf-19, DAF-19A/B, are implicated in the regulation of genes found
in non-ciliated neurons based on the observation that DAF-19A/B isoforms are expressed in all
non-ciliated neurons and only in non-ciliated neurons (Senti & Swoboda, 2008). When DNA
solely expressing DAF-19A is added to worms missing all other DAF-19 proteins, most
behavioral and cellular phenotypes were rescued (Senti & Swoboda, 2008). Therefore, DAF-

Ek-Vazquez, 12

19A/B might regulate genes involved in the maintenance and survival of a healthy nervous
system.
DAF-19A/B transcription factor proteins may bind to DNA sequence motifs similar to xbox motifs bound by DAF-19C and M (see Figure 7; Senti & Swoboda, 2008). Alternatively, DAF19A/B may use other partner proteins, via its dimerization domain, to bind to novel DNA
sequence motifs. Once DAF-19A/B target genes have been characterized, we will be able to
compare promoter regions of these genes to identify common DNA sequence motifs.
Differential regulation of genes in specific types of neurons by different daf-19 isoforms
suggests an important role for daf-19 isoforms in neural development and behavior. In fact, the
mutations to DAF-19A/B transcription factor proteins will provide evidence as to whether or
not these longer daf-19 isoforms control gene expression necessary for protection against
neurodegeneration. Overall, this information highlights the importance of the RFX transcription
factor in both behavior and the development of the nervous system.
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My research aims to (i) identify
neural genes controlled by the DAF-19 RFX
transcription factor, (ii) elucidate whether
daf-19-target genes are controlled by the
DAF-19A/B versions. Finally, (iii) I want to
characterize the expression of genes that
are DAF-19A/B-regulated, and (iv) identify
the cells in which these DAF-19A/BFigure 7. DAF-19 transcription factor proteins
activate genes in ciliated and non-ciliated
neurons. The DAF-19C protein regulates genes
that have a common genetic sequence (called
‘x-boxes’) and that drive ciliogensis. On the
other hand, it is not well known what types of
genes the DAF-19A/B proteins control in order
to indirectly regulate synaptic maintenance.
Taken from Senti and Swoboda, 2008.

regulated genes are differentially
expressed.

Approach: Biological Tools Used to Explore DAF-19 Gene Regulation:
Transcriptome Analysis
The transcriptome is a collection of mRNA expressed in an organism or tissue at the
time that the cells were lysed and RNA collected. De Stasio and Phirke (unpublished) used a
microarray containing probes for 18,000 genes to characterize the transcriptome of adult and
larval worms (respectively). A comparison of the transcriptome of daf-19 null and isogenic wild

Ek-Vazquez, 14

type adult worms suggests both positive and negative regulation of gene expression is
correlated with the presence of DAF-19 proteins.
A transcriptome of daf-19 null animals is a record of all the genes that are activated or
suppressed when all DAF-19 protein versions are gone. For example, if a gene is activated only
when daf-19 is gone, this suggests that in a wild type animal, daf-19 normally represses activity
of that gene either directly or indirectly. On the other hand, if a gene is repressed when daf-19
is gone, but is activated in the presence of daf-19, one can conclude that daf-19 normally
activates this gene in a wild type worm. The transcriptome of wild type worms of matched age
serves as a control, or list of genes that are normally transcribed when all DAF-19 protein
versions are present and functional in C. elegans.
The transcriptome analysis using microarrays identified 170 potential DAF-19A/B
transcription factor protein targets. Thirty-four of these genes were chosen for further analysis
using a transcriptional fusion of the upstream putative control region of our target genes to
DNA encoding GFP. These transcriptional fusions were expressed in isogenic strains to assess
gene expression patterns in the presence and absence of DAF-19 proteins. Isogenic worms have
the same genetic background with the exception of one mutant gene. In this study, daf-19 wild
type (daf-19(WT)) and worms lacking all known DAF-19 proteins, daf-19(m86) worms, were
used to study the regulation of neural genes when DAF-19A/B is mutated or completely nonfunctional. In addition, the De Stasio lab was able to procure DAF-19A/B-specific mutants and
create additional isogenic strains by mating these mutants with worms expressing
transcriptional fusions for our target genes (F57B10.9 and F52D2.2). This means that we can
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assess how daf-19 target neuronal genes are regulated by the DAF-19A/B protein-isoform. So,
not only am I able to distinguish between the effects of different DAF-19 protein versions, I am
also able to discriminate between different parts of a specific DAF-19 protein.
Transcriptional Fusions: Using Fluorescent Proteins to Tag and Visualize a Gene of Interest
How do we know which genes are and which genes are not controlled by certain DAF-19
protein versions? Many biological tools can be used to signal the presence and/or absence of a
particular gene. In my research, I used transcriptional fusions to genetically tag a gene of
interest with a gene that encodes a fluorescent protein (Figure 8). Once a transcriptional fusion
is made, the fluorescent protein will be expressed whenever and wherever the gene of interest
is expressed. Consequently, the fluorescent protein will mimic the expression of any gene we
want by physically tagging that gene. These transcriptional fusion constructs are called
“transgenes” when they are expressed in an animal or plant.
There are different colors of fluorescent proteins: green fluorescent protein (GFP), red
fluorescent protein (RFP), yellow fluorescent protein (YFP), etc. When one of these fluorescent
proteins is illuminated with a particular wavelength of light, that wavelength of light will excite
electrons within the fluorescent protein that will absorb a portion of the light and emit a
wavelength of light that corresponds to the designated color of the protein. As a result of this
color-specific emission and the transparency of C. elegans, we are able to spatially and
temporally localize the expression of any gene.
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Figure 8. Segment of a plasmid that contains the transcriptional fusion
construct. An example of how a fluorescent protein (GFP or RFP) is genetically
tagged onto a gene of interest (i.e daf-19). A 5’ fragment of the target gene
(F57B10.9 and F52D2.2, and daf-19) is fused to a GFP gene to make a
transcriptional fusion. In this construct, the transcription of GFP is driven by the
target gene promoter. Only GFP protein is made from this plasmid construct.
Image adapted from: http://www.nature.com/nrg/journal/v4/n6/fig_tab/nrg1087_F5.html

This construct is known as a transcriptional fusion because although GFP is produced via
the transcriptional control elements of our different target genes, our target genes are not
produced into proteins by the plasmid, though these genes are still being expressed from
normal, chromosomal copies. GFP is, therefore, produced in the cells that express the
transcription factors that bind to the control elements of our target genes, but the GFP protein
does not localize to the specific cellular locations where our target gene functions. Therefore,
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we are not able to draw inferences about the specific locations within a cell where our target
genes (F57B10.9 and F52D2.2) might function by visually localizing the GFP protein.
In order to obtain a temporal representation of reporter gene expression, transgenic
worms of all ages were imaged, thus yielding a developmental representation of the expression
patterns of any reporter gene. In order to identify the ages of individual worms, I compared the
images I produced via confocal microscopy to WormAtlas schematics of the developmental
stages of hermaphroditic worms (Appendix 1A). Similarly, to determine the precise cells in
which the reporter gene is differentially expressed, I compared the images I produced via
confocal microscopy to WormAtlas schematics of neuronal maps (Altun and Hall, 2012). It is
important to note that the absence of fluorescence does not mean that neurons are not
present. Rather, the absence of fluorescence merely means that the reporter gene is not
expressed in the non-fluorescent neurons.
The ability to determine precise expression patterns of each fluorescent, transcriptional
reporter gene has allowed us to characterize not only the location and stage of development at
which genes are transcribed, but also the number of cells in which a reporter gene is
transcribed. Therefore, I have also used transgenes to quantify the difference in the expression
patterns of daf-19 WT worms and daf-19 null mutant worms. Quantifying the expression of
reporter genes is a measure of the penetrance of a gene.
Quantifying the expression of reporter genes is necessary because the expression
patterns of transgenes expressed from extra-chromosomal arrays varies from animal to animal
due to genetic mosaicism. The reporter gene is microinjected into the hermaphrodite gonad
Ek-Vazquez, 18

along with a co-injection marker and carrier plasmid, known as an extra-chromosomal array.
This array is not inherited reliably along with the genomic DNA during cell division.
Consequently, an unstable number of transgene arrays will be present in the progeny of
transgenic worms. In fact, there will also be slight variations in cell-to-cell expression between
individuals of a single strain, thus resulting in mosaicism and an inconsistent pattern of
transgene expression. It is therefore necessary to visualize various individual worms in order to
deduce a representation of transgene expression patterns.
Biological Replicates: “Second Lines” of C. elegans with the Same Transcriptional Fusions
To test whether daf-19 isoforms consistently regulate the same genes, in the same
neurons, at the same stages of development, I have used biological replicates of C. elegans with
the same transcriptional fusions. These biological replicates are called “second lines” because
they are C. elegans strains with transcriptional fusions injected into a different worm’s gonad.
This approach has allowed me to deduce whether I see reproducible differences amongst the
various daf-19 isogenic mutants. If I had not used second lines of C. elegans strains, the
differences in fluorescent gene expression could be attributed to other phenomena.
Obtaining Different daf-19 mutants:
C. elegans mutants were obtained from our collaborators in Stockholm (m86, of5, of6)
and from the Mitani lab in Japan (tm5562). The latter mutant strain was back-crossed in our lab
by Savannah Vogel and Kristen Bischell. Back-crossing mutants reduces any other mutations
that the worm strain might have. Back-crossing involves mating the tm5562 mutant 6
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generations with the wild type strain, OE3738. This process insures that we are only seeing the
effects of an exon 2 deletion to the DAF-19A and B isoforms.
MATERIALS AND METHODS
Maintaining and Constructing C. elegans Strains
C. elegans strains were maintained on 5mm agar plates containing a centered,
standardized quantity of the OP50 E. coli strain, which C. elegans fed on ad libitum. These
plates were kept at 20o C.
C. elegans strains were made with varying daf-19 genetic backgrounds. Consequently,
worms that contained a transgene only had genetic variability in regards to the integrity of the
daf-19 gene. Therefore, in a single strain of C. elegans, identical transgene arrays were
transferred to worms with different daf-19 alleles by mating. Consequently, this approach
allowed us to visualize differential transcription of the fluorescent protein in varying daf-19
genetic backgrounds in vivo.
Dye-Fill Assays:
DiI is commonly used as an anterograde dye. That is, DiI is first absorbed by the cilia on
the dendritic ends of neurons (Figure 4), and it then travels to the axonal projection via the
neuronal body. The ability to absorb DiI requires cilia, therefore, only animals in which DAF-19C
is expressed to drive ciliogenesis—the generation of cilia—are able to absorb the DiI. This
anterograde dye is, therefore, useful to distinguish C. elegans with cilia and therefore
expressing DAF-19C from worms lacking this isoform and therefore also lacking cilia.
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Worms were washed off agar plates with 1 mL of M9 buffer and placed into a 1 mL
Eppendorf. This mix was centrifuged and most of the M9 buffer removed along with bacteria,
leaving a loose pallet of worms. A sufficient volume of M9 was added to the tube to bring the
total volume to 0.5 mL. 3 uL of DiI (2mg/mL) was added to the tube mixture. Worms were then
incubated in the DiI-M9 mixture for one hour at 25oC. Worms were then washed in M9 buffer
once and placed on streaked agar plates containing a standard dose of the OP50 E. coli strain.
Worms were then allowed to eat and defecate for at least 12 hours to remove dye from the
intestinal tract prior to visualization by fluorescent microscopy. This 12 hour recovery period
also helped reduce the intensity of the fluorescent signal from DiI in neurons, thus providing
clearer confocal images.
Confocal Microscopy Preparation and Image Acquisition
Healthy transgenic worms from non-starved NGM plates were collected into an
Eppendorf tube by washing their plates with 1mL of M9 buffer. 1.5mL of 2% agarose in M9
buffer was then heated and mixed with 15uL of sodium azide, to temporarily paralyze the
worms. A thin, circular gel pad was formed by pipetting 5uL of the agarose mixture onto the
center of a glass slide. The circular pad was used to immobilize transgenic worms for confocal
imaging. 3 to 5uL of M9 buffer containing transgenic worms was added onto the gel and a
coverslip was placed on top to prevent it from drying and to facilitate imaging with the use of a
thin piece of glass.
Transgenic worms were imaged with a Leica confocal microscope. Argon and HeNe 543
lasers at 10% power were used along with detectors (HyD) that were set to capture the
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wavelengths of light emitted as GFP and dsRED or DiI (for dye-filled worms). Display colors were
set as green and red, respectively.

RESULTS:
The data collected in the current study supports the hypothesis that F57B10.9 and
F52D2.2 are differentially regulated in specific neurons by DAF-19A/B isoforms. To accomplish
this goal, I examined daf-19 isogenic strains that carried either F57B10.9 or F52D2.2 chimeric
transgenes. That is, I produced worm strains that had mutations in the daf-19 gene and then
mated each of these strains, separately, with a single transgenic strain carrying the GFP
reporter gene for either F57B10.9 or F52D2.2. Specifically, I produced transgenic strains with
the of5, tm5562, and of6 variations of daf-19 to determine if expression of F57B10.9 and
F52D2.2 transgenes is DAF-19A/B dependent. Finally, I compared the images I produced using
confocal microscopy to neuronal schematics in WormAtlas, and thus identified the specific
neurons in which the chimeric transgenes were differentially expressed. By identifying the
neurons expressing the transgene and understanding what the typical functions of these
neurons are, we may be able to gain novel insight into the function of the F57B10.9 and
F52D2.2. Analysis of transcriptional GFP fusion expression patterns by confocal microscopy
revealed reproducible expression of GFP in a subset of neurons in hermaphrodites. A
description of each gene and a detailed analysis of the expression pattern of each
transcriptional fusion is provided below.
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The F57B10.9 Gene
F57B10.9 is orthologous to the human gene SPG20, or Spg-20 (Shaye and Greenwald,
2011; Truong et al., 2015). In fact, a Clustal Omega protein sequence alignment of these genes
found them to have 65% similarity. Mutations in SPG20 which result in the complete loss of
expression of the protein spartin lead to Troyer syndrome (Patel et al., 2002), which is
characterized by spasticity of the leg muscles, progressive muscle weakness, paraplegia, muscle
wasting in the hands and feet (distal amyotrophy), small stature, developmental delay, learning
disorders, speech difficulties (dysarthria), and mood swings, exaggerated reflexes in the lower
limbs (hyperreflexia), skeletal abnormalities, and a bending outward of the knees (valgus)
(Bakowska et al., 2008). The name SPARTIN thus derives from these symptoms: Spastic
Paraplegia Autosomal Recessive Troyer syndrome.
Spartin also shares sequence similarity with spastin (Ciccarelli et al., 2003). The
sequence shared by spartin and spastin is similar to that of proteins involved in the morphology
and membrane trafficking of endosomes—compartments of the endocytotic membrane
transport pathway that originate in the Golgi membrane (Phillips et al., 2002). Most notably,
spastin is thought to be involved in a particular mechanism of endosomal transportation that
involves microtubules (Phillips et al., 2002). When overexpressed, spastin binds to microtubules
and this action results in the redistribution the microtubule array. Spartin shares the N-terminal
region of spastin that is capable of binding to microtubules (Ciccarelli et al., 2003; Renvoise et
al., 2010). Therefore, spartin is predicted to also be involved with microtubule interaction and
trafficking.
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In the nervous system, modest SPG20 expression has been found in fetal and adult
human brains, including the amygdala, cortex, and thalamus (Auer-Grumbach et al., 1999;
Manzini et al., 2010). Lower levels of expression have been found in the hippocampus and
cerebellum. In the mouse brain, SPG20 has similar expression levels to the human brain, except
that higher levels of expression were found in the hippocampus and spinal cord (Manzini et al.,
2010). Additionally, SPG20 has been found to be developmentally regulated, with maximum
expression at midgestation and embryonic day 10 with a precipitous decline thereafter. Even
though SPG20 is present in nervous tissue in fetal stages, only low levels of it are expressed in
the adult mouse brain. Interestingly, SPG20 is present in only low levels of expression in
neurons and glia of the hippocampus and forebrain, and throughout the cerebellum, brainstem,
and spinal cord (Manzini et al., 2010). Due to the large differences in the fluctuation of SPG20
expression levels, it is thought that SPG20 plays a role in morphogenesis and differentiation at
several sites, including the initial frontonasal mass/forebrain, craniofacial structures, aortic
arch/heart primordium, and limb buds during morphogenesis in mice (Manzini et al., 2010). For
these reasons, F57B10.9 was chosen from the list of putative daf-19 regulated genes as possibly
having a role in neuronal function.
Characterizing F57B10.9 Gene Expression
Confocal microscopy was used to image F57B10.9::GFP transgene expression in worms
with different daf-19 genetic backgrounds. F57B10.9::GFP expression was assessed in male and
hermaphrodite worms of all larval stages of development including adulthood. Specifically,
F57B10.9::GFP expression was assessed and recorded in the IL2 neuronal pair, the pharyngeal
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region near the nerve ring; ventral, dorsal, and lateral nerve cords; and in the intestine, body
wall muscle, hypodermis, epidermis, vulva, and tail of each worm (Appendix 1B). Consequently,
I was able to quantify the expression of the reporter transgene in both sexes and deduce a
representation of F57B10.9::GFP expression patterns throughout development.
Previous research by McKay and colleagues (2003) has shown that F57B10.9::GFP
expression occurs in the nerve ring; ventral, dorsal, and lateral nerve cords; and in amphid,
mechanosensory, pharyngeal, and tail neurons of adult worms. Korzynski (2012), Zhang (2013),
and Hurlburt (2014) found similar expression patterns in worms containing all DAF-19 proteins
(daf-19(WT)) and in worms lacking all DAF-19 proteins (daf-19(m86)). Overall, they found that
F57B10.9::GFP was consistently expressed in nerve cords, ventral nerve cord motor neurons,
body neurons, tail neurons, and in approximately 20 neurons in the pharyngeal region. In
addition to its significant presence and role in the nervous system, a 1.58 fold up-regulation of
F5B10.9 mRNA in adult daf-19 mutant worms, makes F57B10.9 a promising DAF-19A/B target
gene. I used previous records of F57B10.9::GFP tissue and neuronal expression to inform my
own investigations. Furthermore, I searched for and recorded the expression of the
F57B10.9::GFP transgene in the tissues where the transgene was previously observed to be
expressed by McKay et al. (2003), Korzynski (2012), Zhang (2013), and Hurlburt (2014).
F57B10.9::GFP expression in daf-19(WT) worms, which contain all DAF-19 isoforms
In worms expressing all DAF-19 proteins, daf-19(WT) worms, F57B10.9 transgene
expression was found to be consistently activated in the ciliated IL2 neurons (indicated by a
dotted square in Figure 9A) and a small cluster of non-ciliated neurons found in the isthmus
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region (Appendix 1B) of the pharynx of hermaphrodite worms (indicated by a dotted circle in
Figure 9A; and Hurlburt, 2014). One hundred percent of worms, 59 total, with a daf-19(WT)
genetic background displayed F57B10.9::GFP expression in the ciliated IL2 sensory neurons. In
addition, one hundred percent of worms displayed expression of the reporter gene in at least
20 neurons in the pharyngeal region, posterior to the IL2 neurons. Further F57B10.9::GFP
expression was also observed in the nerve cords (92%), body neurons (93%), 3-5 tail neurons
(95%), and body wall muscle (63%). These results were consistent across worms of all stages of
larval development and adulthood. In summary, one hundred percent of daf-19(WT) worms,
which contain all DAF-19 proteins, display F57B10.9::GFP expression in the ciliated IL2 neuronal
pair.
F57B10.9::GFP expression in daf-19(m86) worms, which lack all DAF-19 isoforms
Recall that worms that have an m86 mutation in the daf-19 gene lack all DAF-19
proteins and, therefore, cannot produce cilia to absorb DiI. Consequently, these mutants were
identified by their inability to dye-fill and their green transgene fluorescence.
In contrast to daf-19(WT) worms, F57B10.9::GFP transgene expression in worms (N =
31) lacking all DAF-19 proteins (daf-19(m86) mutants) was never found in the ciliated IL2
neuronal pair (indicated by the dotted square in Figure 9B). One hundred percent of all daf19(m86) mutants showed transgene expression in at least 20 neurons in the pharyngeal region,
posterior to the ciliated IL2 neurons (indicated by the dotted circle in Figure 9B). However,
compared to daf-19(WT) worms, F57B10.9::GFP transgene expression in daf-19(m86) mutants
was found in a larger number of neuronal bodies posterior to the anterior bulb of the pharynx.
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Additional transgene expression was also found in the ventral nerve cords (97%), body neurons
(84%), 3-5 tail neurons (97%), and body wall muscle (10%). These results were consistent across
worms of all stages of larval development and adulthood. Conclusively, worms lacking all DAF19 proteins do not express the F57B10.9::GFP transgene in IL2 neurons, but do express the
transgene in a larger number of posterior neuronal bodies than daf-19(WT) worms.
The identity of IL2 neurons was previously determined by Alex Hurlburt (2014); he also
found no age-related difference in transgene expression. The identity of IL2 neurons was
confirmed through a modified calcium acetate dye-fill assay (Appendix 1D; and Tong and
Burglin, 2010; Hurlburt, 2014) that specifically stains IL2 neurons (indicated by white arrows in
Figure 20). Since IL1 neurons are also ciliated and they structurally resemble IL2 neurons, it was
especially crucial to eliminate the IL1 neurons as a possible location for differential
F57B10.9::GFP expression. The only noticeable morphological difference between IL1 neurons
and IL2 neurons is the shape of their axonal projections. The axonal projections of IL2 neurons
have the shape of hooks and they should not interlink (Figure 9). In contrast, the axonal
projections of the IL1 neurons are barely separated from one another and they are much more
dispersed (Figure 9). Notice how the morphology of these two different types of neurons is
indistinguishable (Figure 9).
Thus far, this investigation has added to the findings of Korzynski (2012), Zhang (2013),
and Hurlburt (2014) in that daf-19(WT) worms and worms lacking all DAF-19 proteins (daf19(m86)) showed differences in F57B10.9::GFP expression pattern. Most notably, daf-19(WT)
worms express F57B10.9::GFP in IL2 neurons while daf-19(m86) mutants did not. In addition,
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daf-19(m86) mutants showed transgene expression in a larger number of neuronal bodies in
the posterior region of the pharynx. Consequently, worms with a daf-19(WT) and daf-19(m86)
genetic background have been pivotal in understanding the effects of DAF-19 proteins on
F57B10.9::GFP expression. However, these genetic backgrounds are not sufficient to
understand the isoform-specific roles of different DAF-19 isoforms on F57B10.9::GFP
expression. Thus, the rest of my investigations involved characterizing the expression patterns
of the F57B10.9::GFP transgene in different DAF-19A/B genetic backgrounds.

Ek-Vazquez, 28

Figure 9. Axonal projections of IL1 neurons and IL2 (Fig 10) neurons are indistinguishable.
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Left-side image of IL2 neurons (6 total) taken from WormAtlas.

Calcium acetate staining to identify IL2 neurons (white arrow).
Green: F57B10.9::GFP. Red: DiI. Image taken from Alex Hulrburt
(2014). White scale bars are 20 µm.

daf-19(WT) worms display F57B10.9::GFP expression in IL2 neurons
(white arrow). Green: F57B10.9::GFP. Red: DiI. Image taken from
Alex Hurlburt (2014). White scale bars are 20 µm.
Figure 10. Using calcium acetate staining to identify IL2 neurons.

F57B10.9::GFP expression in daf-19(of5) worms, which lack DAF-19A and B isoforms
F57B10.9::GFP transgene expression in worms lacking the DAF-19A/B proteins, that is
worms with a daf-19(of5) mutant background, revealed GFP expression in the ciliated IL2
neurons (indicated by dotted square in Figure 12D) of every worm analyzed (N = 41).
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Interestingly, 20% of the worms analyzed showed F57B10.9::GFP expression in only two of the
three IL2 neuronal pairs. The IL2 neuronal pair that did not exhibit F57B10.9::GFP expression
varied tremendously; thus, F57B10.9::GFP expression was not consistently present or absent in
a specific neuronal subset of IL2 pairs. On the other hand, F57B10.9::GFP expression was
observed in all three IL2 neuronal pairs in 70% of the worms analyzed.
In addition, F57B10.9::GFP expression was always found in a cluster of neuronal bodies
posterior to the IL2 neuronal pairs (indicated by dotted circle in Figure 12D). Even more
specifically, neuronal bodies were always found both anterior and posterior to the nerve ring.
The number of posterior neuronal bodies expressing F57B10.9::GFP is much larger in daf19(of5) animals than that seen in daf-19(WT) animals. In fact, the larger number of posterior
neurons expressing the transgene resembles the transgene expression levels present in daf19(m86) mutants.
Additional expression of the transgene was observed in the nerve cords (100%), body
wall muscle (93%), and tail neurons (100%). Transgene expression was not, however, observed
in the intestine (0%) or vulva’s (0%) of worms. The expression of the transgene in all of these
different tissues and neurons did not differ across different larval stages of development or
adulthood. Transgene expression patterns were developmentally consistent from the first larval
stage (L1) to old adult worms (OA).
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F57B10.9::GFP expression in daf-19(tm5562) worms, which lack exon two of DAF-19A/B
Worms that have a tm5562 mutation in the daf-19 gene lack exon two of the DAF-19 A
and B isoforms and, therefore, can still produce cilia to absorb DiI. Consequently, these mutants
were identified by their green transgene fluorescence and their ability to dye-fill.
Similar to daf-19(WT) worms, F57B10.9::GFP transgene expression in daf-19(tm5562)
worms was always found in ciliated IL2 neurons (indicated by dotted a square in Figure 12C).
However, F57B10.9::GFP transgene expression in daf-19(tm5562) mutants was consistently
found in a larger number of neuronal bodies posterior to the anterior bulb of the pharynx
(indicated by dotted circle in Figure 12C).Transgene expression in daf-19(tm5562) mutants
occurred in a larger number of posterior neurons than transgene expression in daf-19(WT)
worms (indicated by the dotted circle in Figure 11A). Transgene expression in the posterior
neurons of daf-19 (tm5562) mutants is, therefore, most like that of daf-19(m86) mutants.
However, transgene expression in the ciliated IL2 neurons of daf-19(tm5562) mutants is most
similar to transgene expression in the IL2 neurons of mutants which lack all DAF-19 proteins,
daf-19(m86) mutants (indicated by dotted square in Figure 11B). Additional transgene
expression was also found in the ventral nerve cords (95%), body neurons (100%), 3-5 tail
neurons (92%), and body wall muscle (92%). However, transgene expression was not observed
in the intestine (0%) or vulva’s of daf-19(tm5562) worms (0%).
While these transgene expression patterns were found to be consistent across all stages
of larval development and adulthood, it is important to note that the high consistency of
F57B10.9::GFP expression in body wall muscle was unique to daf-19(tm5562) mutants (92%)
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and daf-19(WT) worms (63%). In contrast, only ten percent of daf-19(m86) worms displayed
F57B10.9::GFP expression in the body wall muscle. Therefore, while F57B10.9::GFP expression
is downregulated in response to the absence of all DAF-19 proteins (daf-19(m86) mutants), its
expression is aberrantly upregulated when worms lack only the amino acids encoded by exon
two of the DAF-19A/B isoforms—the daf-19(tm5562) mutation.
F57B10.9::GFP expression in daf-19(of6) worms, a mutation to DAF-19B
The of6 mutation only alters the DAF-19B isoform. By altering the DAF-19B isoform of a
F57B10.9::GFP transgenic strain, I was able to visualize and understand how these alterations
affect the F57B10.9::GFP expression. The following results are, therefore, a record of how
F57B10.9::GFP expression varies in a genetic background where the DAF-19B isoform has been
altered. It is important to recall that transgene expression was carefully documented in the
specific tissues and cells that include the IL2 neurons; the dorsal, ventral, and lateral nerve
cords; ventral nerve cord motor neurons, intestine, body wall muscle, hypodermis, epidermis,
vulva, and tail of each worm (N = 24).
F57B10.9::GFP expression in a daf-19(of6) mutant background was always found in IL2
neurons (indicated by a dotted square in Figure 12E) and in the posterior cluster of neurons
(indicated by a dotted circle in Figure 12E). Specifically, transgene expression always occurred in
cells both anterior and posterior to the nerve ring. However, F57B10.9::GFP transgene
expression did not occur in as many cell bodies as in the daf-19(m86) genotype. In fact, it seems
to be expressed in few neuronal bodies—an expression pattern very similar to that of
F57B10.9::GFP expression in a daf-19(WT) background (indicated by dotted circle in Fig. 11A).
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Additional F57B10.9::GFP expression was found in the ventral nerve cords (100%), body
neurons (100%), body wall muscle (83%), hypodermis (96%), and tail neurons (100%). While the
transgene was expressed in multiple tissues, the expression of the transgene remained
consistent throughout all larval stages and adulthood. In summary, worms with an altered DAF19B isoform express the F57B10.9::GFP transgene in IL2 neurons, but they only express the
transgene in a small number of neuronal bodies posterior to the IL2 neurons.
F57B10.9::GFP expression in worms that overexpress the DAF-19C isoform
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a
transgene containing a cDNA copy expressing DAF-19C, the F57B10.9::GFP transgene was
always expressed in all three IL2 neuronal pairs (indicated by a dotted square in Figure 13F).
That is, when only DAF-19C is overexpressed in worms that previously lacked transgene
expression in IL2 neurons, F57B10.9::GFP expression is “rescued” in all three IL2 neurons with
one hundred percent penetrance. That is, F57B10.9::GFP expression goes back to “normal”
when DAF-19C is overexpressed in worms that previously lacked all DAF-19 proteins. This
transgene expression pattern in the IL2 neurons, therefore, resembles that seen in worms
containing all DAF-19 proteins (daf-19(WT) worms). Overall, transgene expression in IL2
neurons is similar in worms that exclusively overexpress DAF-19C, daf-19(WT) worms, daf19(of6) mutants, daf-19(of5) mutants, and daf-19(tm5562) mutants.
In worms that overexpress only the DAF-19C isoform, F57B10.9::GFP expression always
occurred in a small cluster of neurons posterior to the IL2 neurons (indicated by a dotted circle
in Figure 13F). More specifically, the transgene expression that occurred in neurons posterior to
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the IL2 neurons occurred in both anterior and posterior locations relative to the nerve ring. Low
levels of transgene expression in the posterior neurons were also seen in daf-19(WT) worms.
Additional F57B10.9::GFP expression was found in the ventral nerve cords (83%) and tail
neurons (100%). The expression patterns that I observed in this DAF-19C rescue were
consistent in at all stages of development and adulthood. I can thus conclude that DAF-19C is
not responsible for WT expression of F57B10.9 in neurons posterior of the nerve ring.
F57B10.9::GFP expression in worms that overexpress the DAF-19A isoform
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a
transgene containing a cDNA copy expressing DAF-19A, the F57B10.9::GFP transgene was never
expressed in IL2 neurons (indicated by dotted square in Figure 13G). That is, transgene
expression in the IL2 neurons of worms that previously lacked all DAF-19 proteins, was not
rescued with the overexpression of DAF-19A. Therefore, DAF-19A overexpression was not
sufficient to activate transgene expression in the ciliated IL2 neurons and produce a genotype
and phenotype that resembles transgene expression in daf-19(WT) worms.
Worms overexpressing DAF-19A always show F57B10.9::GFP expression in the same 3
cell bodies (indicated by dotted circles in Figure 13G), which reside in the general pharyngeal
region. Two of these three cell bodies were identified as neurons. To identify which specific
neurons these were, I compared the confocal images that I produced to WormAtlas schematics
of neurons in the pharyngeal region (Appendix 1B). The morphology of their axonal projections,
cell bodies, and dendritic branching resembles that of the I5 and either the OLQ or OLL neuron.
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Fig 14. Summary of F57B10.9::GFP Expression in Different daf-19 Backgrounds
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F52D2.2 (rgs-8.1) Gene Background
The F52D2.2 gene was chosen for analysis based on its orthology to the human gene,
RGSL1 (regulator of G-protein signaling like 1) and members of the RGS (regulators of G-protein
signaling) family including RGS13. F52D2.2 gene has five exons and it encodes a protein that
regulates other proteins. More specifically, F52D2.2, or rgs-8.1, is a regulator of G-protein
signaling. G proteins—which belong to a group of enzymes called GTPases—are a family of
proteins inside cells that transmit stimuli outside of a cell to the cell’s interior. The activity of G
proteins is regulated by factors that control their ability to bind to and hydrolyze GTP and GDP.
When G proteins are bound to GTP, they are activated. However, when they are bound to GDP,
they are deactivated.
Evidence of differential F52D2.2::GFP expression in worms of different developmental
stages with different daf-19 genetic backgrounds made the F52D2.2 gene an especially
interesting DAF-19 target gene to explore. The transcriptome microarray of three-fold stage
embryos (indicated by a red circle in Appendix 1C) revealed that, when compared to
F52D2.2::GFP expression levels in daf-19 wild type embryos, daf-19(m86) embryos
demonstrated a 0.66 fold decrease in the levels of transgene expression (Phirke, 2011).
Meanwhile, the expression levels of the transgene was less severely impacted in daf-19 mutant
worms at the L1 larval stage of development. In contrast, De Stasio’s analysis of adult worms
revealed that in daf-19(m86) mutants, transgene expression levels were reduced (0.36 fold)
when compared to the expression levels of the transgene in daf-19 wild type worms (De Stasio,
unpublished).
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Due to its reduced levels of expression across different stages of development in the
presence and absence of daf-19, F52D2.2 was investigated as a possible DAF-19A/B target
gene. Bonnie Arbuckle (unpublished) from the De Stasio lab previously characterized the
expression of the F52D2.2::GFP transgene in both a daf-19(WT) and daf-19(m86) genetic
background.

Characterizing F52D2.2 Gene Expression
A transcriptional fusion consisting of 2677 base pairs of DNA upstream of the ATG start
codon of F52D2.2 was fused to the coding region of GFP, thus yielding the F52D2.2::GFP
transgene that spatially and temporally mimics the expression of the F52D2.2 gene. Confocal
microscopy was used to image and analyze F52D2.2::GFP expression in male and
hermaphrodite worms with different daf-19 genetic backgrounds at all stages of larval
development and adulthood. Consequently, I was able to quantify the expression of the
reporter gene in both sexes and deduce a representation of F52D2.2::GFP expression patterns
throughout development. Finally, I used previous records of F52D2.2::GFP cell and tissue
expression to inform my own investigations. Furthermore, I searched for and recorded the
expression of the F52D2.2::GFP transgene in the tissues where the transgene was previously
observed to be expressed by Bonnie Arbuckle (unpublished).
Bonnie Arbuckle (unpublished), from the De Stasio lab, noted F52D2.2::GFP expression
in worms with a daf-19+ and a daf-19- genetic background. While Arbuckle recorded the
expression of the transgene in various cells and tissues, she eventually determined that the only
transgene expression differences amongst daf-19+ and a daf-19- worms existed in the ventral in
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the I2 neuronal pair (Figure 15). I have confirmed the identities of these neurons by comparing
Arbuckle’s confocal images to neuronal schematics on WormAtlas (Figure 15).
In daf-19(WT) animals (N = 37), Arbuckle noticed that 25% of worms analyzed expressed
the transgene in the ventral nerve cord (indicated by white arrows in Figure 16A). However,
none of these worms displayed transgene expression in I2 neurons (indicated by dotted circle in
Figure 16A). Arbuckle’s findings revealed additional transgene expression in tail neurons
(100%). However, transgene expression was never observed in the body wall muscle,
hypodermis, or epidermis of daf-19(WT) worms. The expression patterns observed both by me
and by Bonnie Arbuckle are representative of all stages of larval development and adulthood.
Patterns of F52D2.2::GFP expression are, therefore, consistent throughout the development of
C. elegans.
F52D2.2::GFP expression in daf-19(m86) worms, which lack all DAF-19 isoforms
Next, the F52D2.2::GFP extrachromosomal array was transferred to daf-19(m86) worms
(N = 36), which lack all DAF-19 isoforms. F52D2.2::GFP expression was imaged and analyzed in
the I2 neurons and in the VNC of worms with a daf-19(m86) genetic background. As a result,
Arbuckle (unpublished) noticed that the transgene was expressed in the VNC (indicated by
white arrows in Figure 16B) with 60% penetrance. Thus, transgene expression in the VNC was
preserved in the absence of all DAF-19 proteins. It is important to note that the penetrance of
the transgene’s expression in the VNCs of worms analyzed was higher in worms with a daf19(m86) background, 60%, than worms with a daf-19(WT) background, 25%.
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Arbuckle also noticed that, in 70% of worms, the transgene was expressed in an
additional pair of neurons—the I2 neurons (indicated by the dotted circle in Figure 16B).
Therefore, in daf-19(m86) mutants, the transgene is consistently expressed in an extra pair of
neuronal bodies when compared to transgene expression in daf-19(WT) worms. My own
investigations confirmed Arbuckle’s findings and revealed additional transgene expression in
tail neurons (100%). However, I did not find transgene expression in the body wall muscle,
hypodermis, or epidermis of daf-19(WT) worms. The expression of the transgene was variable,
but overall, it was consistent across all stages of larval development and adulthood.
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WormAtlas illustration of I2 neurons(top). GFP
expression in left and right IL2 neurons (bottom).

F52D2.2::GFP expression in a daf-19(m86)
background. The transgene is expressed in I2 neurons
(dotted circle) and in the VNC (white arrows).

F52D2.2::GFP expression in a daf-19(of5) background.
The transgene is expressed in I2 neurons (dotted
circle) and in the VNC (white arrows).
Figure 15. F52D2.2::GFP expression in I2 neurons is only seen in worms with a
daf-19(m86) and a daf-19(of5) genetic background. Notice the similarity in the
unique anterior process (green arrows) of I2 neurons. I2 neurons were identified by
comparing the images I produced via confocal microscopy to I2 neuronal
schematics on WormAtlas. White bars: 20 µm.
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F52D2.2::GFP expression in daf-19(of5) worms, which lack the DAF-19A and B isoforms
While transgene expression was characterized in the presence and absence of all DAF19 isoforms, analysis of daf-19(WT) and daf-19(m86) worms is not sufficient to understand the
isoform-specific roles of DAF-19A/B. The chimeric transgene was, therefore, transferred to daf19(of5) mutants (N = 30), which possess a mutation that renders the DAF-19A and B isoforms
non-functional. Consequently, the following results characterize the expression patterns of
F52D2.2::GFP in worms lacking solely the DAF-19A/B isoforms.
Seventy percent of daf-19(of5) worms analyzed displayed F52D2.2::GFP expression in
the I2 neuronal pair (indicated by a dotted circle in Figure 17D). Transgene expression was also
found in the VNCs of all worms analyzed (indicated by white arrow in Figure 17D). This
transgene expression pattern is similar to that seen in daf-19(m86) mutants. Additional
transgene expression was found in other body neurons (13%), cells near the vulva (< 1%),
hypodermis (< 1%), and tail neurons (100%). While transgene expression in daf-19(of5) mutants
was variable, especially in body neurons, it is important to note that these results are a
collective representation of mosaic, extra-chromosomal F52D2.2::GFP expression across all
developmental stages including adulthood. The expression patterns provided are, therefore,
developmentally consistent.
F52D2.2::GFP expression in daf-19(tm5562) worms, which lack exon two of DAF-19A/B
The previous investigation of F52D2.2::GFP expression in mutants lacking solely DAF19A/B was further narrowed by exploring the role of a specific amino acid sequence in the DAF19A/B isoforms. The daf-19(tm5562) mutant provides the opportunity for such an analysis. The
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tm5562 mutation in daf-19 is a deletion to solely the second exon of both DAF-19A and B
isoforms. By transferring the F52D2.2::GFP transgene to a daf-19(tm5562) genetic background,
I was able to visualize and record the expression patterns of the transgene in worms that lack
the amino acid sequence encoded by exon 2 of the DAF-19A and B isoforms.
Confocal imaging of several daf-19(tm5562) worms (N = 36) revealed the complete
absence of F52D2.2::GFP expression in I2 neurons (indicated by a dotted circle in Figure 17C).
Therefore, a complete loss of the amino acids encoded by exon 2 of the DAF-19A/B isoforms
does not result in transgene expression in the I2 neurons. It is important to note, however, that
F52D2.2::GFP expression still occurs in the ventral nerve cord (25%, white arrow in Figure17C).
The expression patterns collected via confocal microscopy for daf-19(tm5562) mutants
expressing F52D2.2::GFP are consistent throughout all developmental stages.
F52D2.2::GFP expression in daf-19(of6) worms, a mutation to DAF-19B
Worms (N = 36) with a mutation to DAF-19B never showed F52D2.2::GFP expression in
the I2 neurons (indicated by dotted circle in Figure 17E). However, transgene expression in daf19(of6) mutants was always observed in the VNC of these animals. The overall transgene
expression pattern in daf-19(of6) mutants resembles that seen in wild type animals, which
contain all DAF-19 proteins. Since transgene expression was not upregulated in the absence of
DAF-19B, it clear that the suppression of F52D2.2::GFP expression is not dependent on DAF19B.
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F52D2.2::GFP expression in worms that overexpress the DAF-19C isoform
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a
transgene containing a cDNA copy expressing DAF-19C, the F52D2.2::GFP transgene was never
expressed in I2 neurons (indicated by dotted circle in Figure 18F) or in the ventral nerve cords
of animals (indicated by white arrows in Figure 18F). That is, when only DAF-19C is
overexpressed in worms that previously displayed transgene expression in I2 neurons,
F52D2.2::GFP expression is completely lost in all dye-filling worms overexpressing DAF-19C. This
complete loss of transgene expression in the I2 neurons and in the VNC is, therefore, a unique
expression pattern that is exclusive to worms overexpressing DAF-19C.
F52D2.2::GFP expression in worms that overexpress the DAF-19A isoform
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a
transgene containing a cDNA copy expressing DAF-19A, the F52D2.2::GFP transgene was never
expressed in I2 neurons (indicated by dotted circle in Figure 18G).
That is, transgene expression in the I2 neurons of worms that previously lacked all DAF19 proteins, was not rescued with the overexpression of DAF-19A (indicated by dotted circle in
Figure 18G). Therefore, DAF-19A overexpression was not sufficient to activate transgene
expression in the ciliated IL2 neurons and produce a genotype and phenotype that resembles
transgene expression in daf-19(WT) worms.
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Worms overexpressing DAF-19A consistently show F52D2.2::GFP expression in 2-5
previously unseen neuronal bodies (indicated by dotted circles in Figure 18G), which reside in
the general pharyngeal region. I identified one of these cell bodies as the I5 neuron (blue arrow
in Figure 19). To identify which specific neurons these were, I compared the confocal images
that I produced to WormAtlas schematics of neurons in the pharyngeal region (Figure 19)
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Confocal image shows I5 neuron. Green: F52D2.2::GFP expression in a worm overexpressing DAF19A is present in several cell bodies, including the I5 neuron (blue arrow).

WormAtlas neuronal schematic of an I5 neuron.

Figure 19. The morphology of the neuron (blue arrow) present in the confocal image (top)
matches the unique morphology of the I5 neuronal schematic provided by Worm Atlas.
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Fig. 20 Summary of F52D2.2::GFP Expression in Various daf-19 Backgrounds
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DISCUSSION:
F57B10.9 Expression is both activated and repressed by DAF-19 isoforms
F57B10.9::GFP expression was consistently found in nervous tissue that includes nerve
cords, neurons in the pharyngeal region of the head, tail neurons, and along the ventral body
wall. Previous work by Alex Hurlburt (2014) revealed the identity of some neuronal bodies
where transgene expression was DAF-19 dependent. Most notable, is the difference in the
expression of the transgene in the IL2 neurons. Hurlburt (2014) not only identified these
neuronal cell bodies as IL2 neurons via a modified calcium acetate dye-filling, but he also
determined that only daf-19+ worms expressed the transgene in IL2 neurons.

By knocking down and overexpressing different DAF-19 isoforms, I have determined
that F57B10.9::GFP expression in IL2 neurons was only observed in worms in which the DAF19C isoform was expressed. Transgene expression in IL2 neurons was first observed in daf-19
wild type worms, which contain all DAF-19 isoforms. However, when all DAF-19 proteins were
knocked out, transgene expression in IL2 neurons was also lost. At this point in the investigation
we knew that transgene expression in the IL2 neurons was activated by the daf-19 gene.
However, this was not sufficient information to deduce which specific DAF-19 isoform was
responsible for activating the expression of the transgene in IL2 neurons. Therefore, the of5,
tm5562, of5, and of6 mutations in the daf-19 gene were instrumental to discovering the
isoform-specific functions of the different DAF-19 isoforms.
In the De Stasio lab, we specifically seek to understand how the DAF-19A and B isoforms
regulate neuronal genes. To understand the functions of the DAF-19A and B isoforms, we
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decided to knock down these two DAF-19 isoforms and observe transgene expression in this
genetic background in vivo; thus, allowing the intact organism to demonstrate the effects of
non-functional DAF-19A/B on F57B10.9::GFP expression. The consistent expression of the
transgene in the IL2 neurons of worms lacking both DAF-19A and B isoforms suggests that
transgene expression in IL2 neurons is DAF-19A/B independent. DAF-19A/B independence in IL2
neurons is further supported by the consistent expression of the transgene in the IL2 neurons
of daf-19(of5), daf-19(tm5562), and daf-19(of6) mutants—all of which contain mutations in
only the DAF-19A and/or B isoforms. Moreover, the loss of transgene expression in the IL2
neurons in daf-19(m86) mutants was rescued by solely overexpressing DAF-19C. This suggests
that transgene expression in IL2 neurons is DAF-19C dependent. We can, therefore, infer that
F57B10.9 expression is also DAF-19C dependent in IL2 neurons. In conclusion, DAF-19C is
necessary for the expression of F57B10.9::GFP expression in IL2 neurons. My investigations,
however, do not answer whether DAF-19C is sufficient for the transgene expression in IL2
neurons. There are many other proteins that regulate the control elements of gene
transcription and mRNA translation.
Compared to daf-19(WT) worms, animals with mutations specific to the DAF-19A and B
isoforms consistently showed differential transgene expression in a cluster of neurons posterior
to the IL2 neurons. When all DAF-19 proteins were completely abolished, transgene expression
was consistently found in a larger number of neuronal bodies located posteriorly to the IL2
neurons (Hurlburt, 2014). At this point in time, the data collected suggested that transgene
expression in those posterior neuronal bodies was DAF-19 dependent. More specifically, since
transgene expression was upregulated in the absence of all DAF-19 isoforms, it was evident that
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F57B10.9::GFP expression was normally repressed by daf-19. However, since we are particularly
interested in the isoform specific functions of the DAF-19A and B isoforms, I transferred the
transgene into several daf-19a/b mutants.
As hypothesized, F5210.9::GFP expression in the posterior neurons of daf-19(of5)
mutants was indeed upregulated. Therefore, completely non-functional DAF-19A and B
isoforms are associated with the upregulation of F57B10.9::GFP in neurons posterior to the IL2
neurons. Therefore, it is clear that transgene expression in the cluster of posterior neuronal
bodies is normally suppressed by DAF-19A and B isoforms. That is, transgene expression in the
aforementioned posterior neurons is dependent on DAF-19A/B for suppression. Interestingly, I
have associated this transgene suppression with the specific amino acid sequences encoded by
exon two of the DAF-19A and B isoforms.
Transgene expression in daf-19(tm5562) mutants is upregulated, suggesting that, in wild
type worms the amino acids encoded by exon two largely contribute to the suppression of
transgene expression in the aforementioned posterior neuronal cell bodies. Since a similar
transgene expression was seen in daf-19(of5) mutants, I decided to rescue the DAF-19A isoform
by overexpressing it. The purpose of overexpressing DAF-19A is to determine whether
suppression of the transgene in the posterior neuronal bodies would be re-established to
resemble wild type worms. As a result, transgene suppression in the posterior neurons was
indeed re-established but to an even greater degree than in wild type worms. The
overexpression of DAF-19A, therefore, over-suppresses transgene expression in neuronal
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bodies posterior to the IL2 neurons. Another study may, instead, only rescue the amino acids
encoded by exon 2 of the DAF-19 A and B isoforms.

F52D2.2 Expression
F52D2.2::GFP expression was consistently found in the nervous system. With exception
to the DAF-19C rescue, transgene expression was always found in the ventral nerve cord of
worms. Wild type worms showed consistent transgene expression in the ventral nerve cord.
However, in the absence of all DAF-19 proteins, transgene expression was seen in an additional
pair of neurons, which I hypothesize to be the I2 neuronal pair. Since transgene expression is
upregulated in the absence of DAF-19, this suggests that transgene suppression is dependent of
DAF-19. My investigations with the other daf-19 genetic mutants revealed novel isoformspecific regulatory roles for DAF-19 A and B.
Only daf-19(m86) mutants and worms lacking both DAF-19A and B isoforms (daf-19(of5)
mutants) displayed transgene expression in I2 neurons. Consequently, our hypothesis that DAF19A/B may regulate F52D2.2 expression is supported by the data collected from the daf-19(of5)
mutant. However, further investigation led me to exclude transgene suppression in the I2
neurons as solely DAF-19B dependent. When only DAF-19B is altered, as is the case in the daf19(of6) mutation, transgene expression is not seen in I2 neurons, but only seen in the ventral
nerve cord. This suggests DAF-19B is either not involved in the suppression of F52D2.2
expression, or it is not sufficient to repress the expression of the transgene in I2 neurons.
Since the DAF-19B isoform is either not necessary or sufficient to suppress F52D2.2::GFP
expression, I continued to investigate the regulatory role of the DAF-19A/B isoforms on
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F52D2.2 expression. The extrachromosomal array was transferred to a daf-19(tm5562) genetic
background. Consequently, I was able to see the effects of losing exon 2 of the DAF-19 and B
isoforms on F52D2.2 expression. In daf-19(tm5562) animals, transgene expression was
consistently observed in the I2 neurons, thus suggesting that the amino acids encoded by exon
2 of the DAF-19A and B isoforms is either necessary or sufficient (or both) to suppress the
expression of the transgene in I2 neurons.
Overexpressing DAF-19C resulted in the complete suppression of the transgene.
Therefore, overexpression of DAF-19C is associated with downregulation of F52D2.2
expression. It is important to note that wild type levels of DAF-19C expression are associated
with transgene expression in the ventral nerve cord. However, once over expressed, DAF-19C
represses the transgene in the same location. This study, therefore, has revealed that F52D2.2
expression and repression is dose dependent on the levels of DAF-19C expression.
By adding back DAF-19A to daf-19(m86) mutants, I hoped to determine whether the
suppression of the transgene would be re-established. Interestingly, since DAF-19A was not
expressed in wild type levels, but instead overexpressed, the transgene was consistently
expressed in previously unseen neurons. One of these neurons was identified as the I5 neuron.
The effects of DAF-19A overexpression on F52D2.2 expression has, therefore, proven to be
unpredictable.
CONCLUSIONS AND FUTURE RESEARCH
This study demonstrated that F57B10.9 expression is both activated and repressed by
DAF-19 proteins. More specifically, I showed that in the IL2 neurons, DAF-19C is responsible for
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the activation of F57B10.9::GFP expression. Simultaneously, I found that DAF-19 normally
represses F57B10.9::GFP expression in neuronal bodies posterior to the nerve ring. More
specifically, I was able to associate loss of transgene repression with the loss of the amino acids
encoded by exon two of the DAF-19A and B isoforms. Next, I determined which DAF-19
isoform, or combination thereof, is necessary and/or sufficient to maintain F57B10.9::GFP
repression in the posterior neuronal bodies. I found that the of6 mutation to DAF-19B was not
sufficient to inhibit transgene repression in the posterior cluster of neuronal bodies. In these
daf-19(of6) mutants, DAF-19A was still normally expressed, which suggests that the integrity of
DAF-19A expression is sufficient to maintain repression in the posterior cluster of neurons.
Moreover, this suggests that the amino acids rendered non-functional in daf-19(of6) mutants
are not necessary for transgene repression in the posterior cluster of neurons. This study also
demonstrated that F52D2.2::GFP suppression is maintained by the amino acid sequences
encoded by exon 2 of the DAF-19A and B isoforms. Further investigations could focus on
identifying the specific neurons in which F57B10.9 and F52D2.2 are differentially expressed.
Understanding the role of these specific neurons in the nervous system can guide future
investigations into how the DAF-19 isoforms might affect the function of specific neural circuits.
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APPENDIX 1

Appendix 1A. C. elegans larval stages of development.
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Appendix 1B. Morphology of C. elegans hermaphrodite.
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Appendix 1C. Life Cycle of C. elegans, taken from “Introduction to C. elegans Anatomy”
(Altun et al., 2002). Circled (red) embryonic stage represents the 3-fold embryonic stage.
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